Nektar Therapeutics: Unique MOA Translates To Stellar AD Maintenance Data, Strong Buy

Nektar Therapeutics is rated Strong Buy based on promising Phase 2b maintenance data for REZPEG in atopic dermatitis. Click to read why NKTR is a Strong Buy.

IDEAYA Biosciences, Inc. (IDYA) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transcript

Citi's 2026 Virtual Oncology Leadership Summit February 18, 2026 1:00 PM ESTCompany ParticipantsJoshua Bleharski - ...
eLife

Temporal dynamics of peri-microsaccadic modulations within the foveola

Stearns and Poletti present a technically impressive study that aims to uncover a deeper understanding of microsaccade function: their role in perceptual modulation and the associated temporal ...
East Coast Radio

Say goodbye to the SRD grant as we know it as SA prepares a new social support plan

The SRD grant will continue at R370 until March 2027, before being redesigned into a new, more sustainable social grant.